Meningococcal Meningitis
📧 Sign up to get email alerts when something new happens for Meningococcal Meningitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Olds [Phase 3]
Phase 3 clinical trial update for ACYW135 group meningococcal polysaccharide conjugate vaccine (CRM197 vector) in adults; the study is curre…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) in Adults Aged 18 to 55 Years [Phase 3]
Phase 3 study evaluating immunogenicity and safety of Group ACYW135 meningococcal conjugate vaccine (CRM197) in adults 18-55, sponsored by C…
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: A Human Controlled Infection Study with Neisseria Lactamica in Malian Adults [NA]
This document notes the completion of a human controlled infection study using Neisseria lactamica in Malian adults, aimed at understanding …
-
CLINICAL_TRIALS research · 2014-09-18Clinical Trial Update: Early Waning of Maternal Measles and Meningitis C Antibodies
Clinical trial update reports early waning of maternal antibodies against measles and meningococcal disease (group C), with potential implic…